Items where Author is "Prakash, Manivasakam"

Group by: Item Type | No Grouping
Number of items: 5.

Pethappachetty, Palanisamy and Kumar, Balamurugan and Govindaraj, Anandharaj and Prakash, Manivasakam and Kumari, Bhuvaneshwari Venkataesan and Venkatesan, Kamalesh Balakumar and Srinivasan, Manoj Kumar (2025) 3D Printing in Personalized Medicine: Revolutionizing Drug Delivery and Healthcare Applications. Biomedical Materials and Devices. ISSN 27314820; 27314812

Pethappachetty, Palanisamy and Thirupathi, Kavya and Moorthy, Phagalavan and Kumar, Mohan and Prakash, Manivasakam and Govindharaj, Anandharaj (2025) Pharmaceutical Manufacturing Sectors Regulatory-Based Operation Management for Parenteral Preparations. INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 15.0 (1). pp. 209-218. ISSN 2230-973X

Pethappachetty, Palanisamy and Thirupathi, Kavya and Moorthy, Phagalavan and Kumar, Mohan and Prakash, Manivasakam and Govindharaj, Anandharaj (2025) Pharmaceutical Manufacturing Sectors Regulatory-Based Operation Management for Parenteral Preparations. INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 15.0 (1). pp. 209-218. ISSN 2230-973X

Palaniyappan, Rajamanickam and Arthanari, Saravanakumar and Subramanian, Mohanraj and Periyasamy, Parthiban and Pethappachetty, Palanisamy and Ganesan, Ragupathi and Prakash, Manivasakam and Govindaraj, Anandharaj (2024) Nanotechnology-Driven Approaches in Overcoming Drug Delivery Challenges for Neurodegenerative Diseases. Indian Journal of Pharmaceutical Education and Research, 58 (4s). s1185-s1200. ISSN 00195464

Palaniyappan, Rajamanickam and Arthanari, Saravanakumar and Subramanian, Mohanraj and Periyasamy, Parthiban and Pethappachetty, Palanisamy and Ganesan, Ragupathi and Prakash, Manivasakam and Govindaraj, Anandharaj (2024) Nanotechnology-Driven Approaches in Overcoming Drug Delivery Challenges for Neurodegenerative Diseases. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 58.0 (4). S1185-S1200. ISSN 0019-5464

This list was generated on Sat Mar 14 04:34:25 2026 IST.